Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKD 13.9
(17.0%)
HKD 13.9
(17.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 544.1 Million CNY | 31.02% |
| 2022 | 415.28 Million CNY | -22.86% |
| 2021 | 538.35 Million CNY | 16.08% |
| 2020 | 463.79 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 395.47 Million CNY | -27.32% |
| 2024 Q2 | 395.47 Million CNY | 45.46% |
| 2023 Q4 | 544.1 Million CNY | 5.09% |
| 2023 FY | 544.1 Million CNY | 31.02% |
| 2023 Q3 | 517.74 Million CNY | 10.37% |
| 2023 Q2 | 469.07 Million CNY | 11.28% |
| 2023 Q1 | 421.54 Million CNY | 1.51% |
| 2022 Q1 | 582.8 Million CNY | 8.26% |
| 2022 FY | 415.28 Million CNY | -22.86% |
| 2022 Q4 | 415.28 Million CNY | 12.13% |
| 2022 Q3 | 370.34 Million CNY | -40.87% |
| 2022 Q2 | 626.37 Million CNY | 7.47% |
| 2021 Q3 | 62.9 Million CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 FY | 538.35 Million CNY | 16.08% |
| 2021 Q4 | 538.35 Million CNY | 755.86% |
| 2020 FY | 463.79 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -929.203% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 90.826% |